157 related articles for article (PubMed ID: 30092227)
1. Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus.
Liu D; Ji L; Zhao M; Wang Y; Guo Y; Li L; Zhang D; Xu L; Pan B; Su J; Xiang S; Pennathur S; Li J; Gao J; Liu P; Willard B; Zheng L
J Mol Cell Cardiol; 2018 Sep; 122():47-57. PubMed ID: 30092227
[TBL] [Abstract][Full Text] [Related]
2. Nonenzymatic glycation of high-density lipoprotein impairs its anti-inflammatory effects in innate immunity.
Liu D; Ji L; Zhang D; Tong X; Pan B; Liu P; Zhang Y; Huang Y; Su J; Willard B; Zheng L
Diabetes Metab Res Rev; 2012 Feb; 28(2):186-95. PubMed ID: 21928330
[TBL] [Abstract][Full Text] [Related]
3. Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.
Nobécourt E; Tabet F; Lambert G; Puranik R; Bao S; Yan L; Davies MJ; Brown BE; Jenkins AJ; Dusting GJ; Bonnet DJ; Curtiss LK; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):766-72. PubMed ID: 20110571
[TBL] [Abstract][Full Text] [Related]
4. Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes.
Dai Y; Shen Y; Li QR; Ding FH; Wang XQ; Liu HJ; Yan XX; Wang LJ; Yang K; Wang HB; Chen QJ; Shen WF; Zhang RY; Lu L
J Am Coll Cardiol; 2017 Oct; 70(16):2006-2019. PubMed ID: 29025558
[TBL] [Abstract][Full Text] [Related]
5. Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism.
Domingo-Espín J; Nilsson O; Bernfur K; Del Giudice R; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2822-2834. PubMed ID: 29802959
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
Lu N; Xie S; Li J; Tian R; Peng YY
Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
[TBL] [Abstract][Full Text] [Related]
7. Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.
Kashyap SR; Osme A; Ilchenko S; Golizeh M; Lee K; Wang S; Bena J; Previs SF; Smith JD; Kasumov T
J Clin Endocrinol Metab; 2018 Feb; 103(2):388-396. PubMed ID: 29077935
[TBL] [Abstract][Full Text] [Related]
8. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L
Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-I inhibits chemotaxis, adhesion, activation of THP-1 cells and improves the plasma HDL inflammatory index.
Wang L; Chen WZ; Wu MP
Cytokine; 2010 Feb; 49(2):194-200. PubMed ID: 19819722
[TBL] [Abstract][Full Text] [Related]
10. Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia.
May-Zhang LS; Yermalitsky V; Melchior JT; Morris J; Tallman KA; Borja MS; Pleasent T; Amarnath V; Song W; Yancey PG; Davidson WS; Linton MF; Davies SS
J Biol Chem; 2019 Dec; 294(50):19022-19033. PubMed ID: 31666337
[TBL] [Abstract][Full Text] [Related]
11. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
[TBL] [Abstract][Full Text] [Related]
12. Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.
Nobécourt E; Zeng J; Davies MJ; Brown BE; Yadav S; Barter PJ; Rye KA
Diabetologia; 2008 Jun; 51(6):1008-17. PubMed ID: 18437350
[TBL] [Abstract][Full Text] [Related]
13. A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins.
Park KH; Cho KH
Fish Shellfish Immunol; 2011 Dec; 31(6):904-10. PubMed ID: 21906681
[TBL] [Abstract][Full Text] [Related]
14. The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta.
Battle S; Gogonea V; Willard B; Wang Z; Fu X; Huang Y; Graham LM; Cameron SJ; DiDonato JA; Crabb JW; Hazen SL
J Biol Chem; 2022 Apr; 298(4):101832. PubMed ID: 35304099
[TBL] [Abstract][Full Text] [Related]
15. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.
Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA
Diabetologia; 2007 Mar; 50(3):643-53. PubMed ID: 17216278
[TBL] [Abstract][Full Text] [Related]
16. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
[TBL] [Abstract][Full Text] [Related]
17. HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications.
Li Y; Zhao M; He D; Zhao X; Zhang W; Wei L; Huang E; Ji L; Zhang M; Willard B; Fu Z; Wang L; Pan B; Zheng L; Ji L
Lipids Health Dis; 2016 Apr; 15():76. PubMed ID: 27074994
[TBL] [Abstract][Full Text] [Related]
18. Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects.
Gomes Kjerulf D; Wang S; Omer M; Pathak A; Subramanian S; Han CY; Tang C; den Hartigh LJ; Shao B; Chait A
J Diabetes Complications; 2020 Dec; 34(12):107693. PubMed ID: 32900591
[TBL] [Abstract][Full Text] [Related]
19. Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages.
Tabet F; Lambert G; Cuesta Torres LF; Hou L; Sotirchos I; Touyz RM; Jenkins AJ; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1192-200. PubMed ID: 21330603
[TBL] [Abstract][Full Text] [Related]
20. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
